Artelo Biosciences Stock Analysis

Artelo Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. Artelo Biosciences recorded a loss per share of 2.87. The entity last dividend was issued on the 21st of June 2019. The firm had 1:15 split on the 10th of August 2022. Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. Artelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Artelo Biosciences please contact Gregory MBA at 858 925 7049 or go to https://www.artelobio.com.

Artelo Biosciences Investment Alerts

Artelo Biosciences Upcoming and Recent Events

Artelo Largest EPS Surprises

View All Earnings Estimates

Artelo Stock Institutional Investors

Note, although Artelo Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Artelo Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.87 M.

Artelo Profitablity

Management Efficiency

Artelo Biosciences has return on total asset (ROA) of (0.5433) % which means that it has lost $0.5433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8858) %, meaning that it created substantial loss on money invested by shareholders. Artelo Biosciences' management efficiency ratios could be used to measure how well Artelo Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.51. Return On Capital Employed is expected to rise to -0.58 this year. At this time, Artelo Biosciences' Intangibles To Total Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.01 this year, although the value of Non Current Assets Total will most likely fall to about 1.5 M.

Technical Drivers

As of the 2nd of February, Artelo Biosciences shows the Mean Deviation of 2.78, downside deviation of 3.65, and Risk Adjusted Performance of 0.027. Artelo Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Artelo Biosciences variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Artelo Biosciences is priced correctly, providing market reflects its regular price of 1.17 per share. Given that Artelo Biosciences is a hitting penny stock territory we recommend to closely look at its total risk alpha.

Artelo Biosciences Price Movement Analysis

Artelo Biosciences Insider Trading Activities

Artelo Biosciences Outstanding Bonds

Artelo Biosciences Predictive Daily Indicators

Artelo Biosciences Forecast Models

Artelo Biosciences' time-series forecasting models are one of many Artelo Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Artelo Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Artelo Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Artelo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Artelo Biosciences. By using and applying Artelo Stock analysis, traders can create a robust methodology for identifying Artelo entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Artelo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Artelo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Artelo Biosciences stock analysis indicators help investors evaluate how Artelo Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Artelo Biosciences shares will generate the highest return on investment. By understating and applying Artelo Biosciences stock analysis, traders can identify Artelo Biosciences position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.